John Higgins

Président chez OMNIAB, INC. Fortune : 11 M $ au 31/05/2026

Profil

John L.
Higgins currently works at Metabasis Therapeutics, Inc., as Chief Executive Officer from 2010, CyDex Pharmaceuticals, Inc., as Chief Executive Officer, OmniAb Operations, Inc., as Chairman from 2022, Academy of Whole Learning, as Chairman, OmniAb, Inc., as Chairman from 2022, Bio-Techne Corp., as Independent Director from 2009, and Pelican, Inc., as Director from 2020.
Mr. Higgins also formerly worked at BioCryst Pharmaceuticals, Inc., as Director from 2004 to 2012, Ligand Pharmaceuticals, Inc., as Director in 2022, CoMentis, Inc., as Director, Blue Zones LLC, as Director, Connetics Corp., as CFO & EVP-Administration & Corporate Development from 1997 to 2006, and Dillon, Read & Co., Inc., as Member-Healthcare Banking Team.
Mr. Higgins received his undergraduate degree from Colgate University.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
OMNIAB, INC. 2,04 %	17/06/2026	2 962 320 ( 2,04 % )	8 M $	31/05/2026
BIO-TECHNE CORPORATION 0,04 %	30/10/2025	66 876 ( 0,04 % )	3 M $	31/05/2026

Postes actifs de John Higgins

Sociétés	Poste	Début
BIO-TECHNE CORPORATION	Directeur/Membre du Conseil	19/05/2009
PFENEX INC.	Directeur/Membre du Conseil	01/10/2020
OMNIAB, INC.	Président	01/11/2022
Metabasis Therapeutics, Inc.	Directeur Général	01/01/2010
OmniAb Operations, Inc.	Président	-
Academy of Whole Learning	Président	-
CyDex Pharmaceuticals, Inc.	Directeur Général	-

Anciens postes connus de John Higgins

Sociétés	Poste	Fin
LIGAND PHARMACEUTICALS INCORPORATED	Directeur Général	05/12/2022
BIOCRYST PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	-
░░░░░░░░░ ░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░	░░░░░░░░░░
░░░░ ░░░░░ ░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-
░░░░░░░░░ ░░░░	░░░░░░░░░░	-